In Vitro Drug Release Testing of Special Dosage Forms
Advances in Pharmaceutical Technology
1. Auflage Dezember 2019
312 Seiten, Hardcover
Wiley & Sons Ltd
Guides readers on the proper use of in vitro drug release methodologies in order to evaluate the performance of special dosage forms
In the last decade, the application of drug release testing has widened to a variety of novel/special dosage forms. In order to predict the in vivo behavior of such dosage forms, the design and development of the in vitro test methods need to take into account various aspects, including the dosage form design and the conditions at the site of application and the site of drug release. This unique book is the first to cover the field of in vitro release testing of special dosage forms in one volume. Featuring contributions from an international team of experts, it presents the state of the art of the use of in vitro drug release methodologies for assessing special dosage forms' performances and describes the different techniques required for each one.
In Vitro Drug Release Testing of Special Dosage Forms covers the in vitro release testing of: lipid based oral formulations; chewable oral drug products; injectables; drug eluting stents; inhalation products; transdermal formulations; topical formulations; vaginal and rectal delivery systems and ophthalmics. The book concludes with a look at regulatory aspects.
* Covers both oral and non-oral dosage forms
* Describes current regulatory conditions for in vitro drug release testing
* Features contributions from well respected global experts in dissolution testing
In Vitro Drug Release Testing of Special Dosage Forms will find a place on the bookshelves of anyone working with special dosage forms, dissolution testing, drug formulation and delivery, pharmaceutics, and regulatory affairs.
Series Preface
Preface
Part I: Oral dosage forms
Chapter 1: Lipid based oral formulations
Chapter 2: Chewable oral drug products
Part II: Non-oral dosage forms
Chapter 3: Injectables
Chapter 4: Drug eluting stents
Chapter 5: In Vitro Dissolution for Inhalation Products
Chapter 6: Topicals and transdermals
Chapter 7: Vaginal and intrauterine delivery systems
Chapter 8: Rectal dosage forms
Chapter 9: Ophthalmic dosage forms
Chapter 10: Regulatory Considerations
Nikoletta Fotaki, PhD, is Reader in Pharmaceutics, Department of Pharmacy and Pharmacology, University of Bath, UK. Her research interests are focused on the prediction of drug absorption through the oral and non-oral route; prediction of drug absorption in special populations (paediatrics; disease states), biorelevant dissolution methods, formulation development, and physiologically based pharmacokinetic modeling.
Sandra Klein, PhD, is Professor of Pharmaceutical Technology, Department of Pharmacy, University Greifswald, Germany. Her research is focused on developing bio-predictive in vitro models and oral dosage forms for special patient groups, particularly the paediatric and geriatric population; the design of predictive and accelerated test methods for lozenges, vaginal delivery systems and depot parenterals, and in establishing formulation strategies for enhancing the bioavailability of poorly soluble drugs.
